1E87 image
Entry Detail
PDB ID:
1E87
Title:
Human CD69 - trigonal form
Biological Source:
Source Organism:
Host Organism:
PDB Version:
Deposition Date:
2000-09-18
Release Date:
2000-09-26
Method Details:
Experimental Method:
Resolution:
1.50 Å
R-Value Free:
0.24
R-Value Work:
0.22
R-Value Observed:
0.22
Space Group:
P 31 2 1
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:EARLY ACTIVATION ANTIGEN CD69
Chain IDs:A
Chain Length:118
Number of Molecules:1
Biological Source:HOMO SAPIENS
Primary Citation
Crystal Structure of the C-Type Lectin-Like Domain from the Human Hematopoietic Cell Receptor Cd69
J.Biol.Chem. 276 7312 ? (2001)
PMID: 11036086 DOI: 10.1074/JBC.M008573200

Abstact

CD69, one of the earliest specific antigens acquired during lymphoid activation, acts as a signal-transducing receptor involved in cellular activation events, including proliferation and induction of specific genes. CD69 belongs to a family of receptors that modulate the immune response and whose genes are clustered in the natural killer (NK) gene complex. The extracellular portion of these receptors represent a subfamily of C-type lectin-like domains (CTLDs), which are divergent from true C-type lectins and are referred to as NK-cell domains (NKDs). We have determined the three-dimensional structure of human CD69 NKD in two different crystal forms. CD69 NKD adopts the canonical CTLD fold but lacks the features involved in Ca(2+) and carbohydrate binding by C-type lectins. CD69 NKD dimerizes noncovalently, both in solution and in crystalline state. The dimer interface consists of a hydrophobic, loosely packed core, surrounded by polar interactions, including an interdomain beta sheet. The intersubunit core shows certain structural plasticity that may facilitate conformational rearrangements for binding to ligands. The surface equivalent to the binding site of other members of the CTLD superfamily reveals a hydrophobic patch surrounded by conserved charged residues that probably constitutes the CD69 ligand-binding site.

Legend

Protein

Chemical

Disease

Primary Citation of related structures